Government Affairs
Refine Search
Pharmaceutical
The Spanish government has confirmed its interest in Spain hosting the European Medicines Agency (EMA) if it moves from its current UK base following the vote for Brexit in last month’s referendum. 6 July 2016
Pharmaceutical
A group of four pharma industry associations have signed a memorandum of understanding in China to adopt pro-medicine and patient-centered principles, build public consensus on the value of medical representatives and establish a national system to manage them, and promote proper and orderly development of the sector. 29 June 2016
Biotechnology
The boss of one of Europe’s leading biotech companies tells The Pharma Letter that it cannot now consider teaming up with UK researchers because of fears that such partnerships will lose European Union (EU) funding. 27 June 2016
Pharmaceutical
Britain's unexpected vote on Thursday to leave the European Union, which saw currency and stock markets in turmoil in Friday, has left many scrambling to determine the impact on markets and various sectors. 26 June 2016
Pharmaceutical
The Russian government has appointed the National immuno-biological company (Natsimbio), the recently established Russian drugmaker which is part of the Russian state and defense corporation Rostec, as sole supplier of blood plasma drugs for the period of 2016-2017 years through the signing of a contract with the company. 24 June 2016
Pharmaceutical
As reported earlier today, the UK has voted to leave the European Union, with the news sending sterling and stocks into turmoil, as well as the resignation of Prime Minister David Cameron. 24 June 2016
Pharmaceutical
The UK has spoken. The Referendum on Thursday, which saw a massive turnout of over 70%, resulted in a vote to leave the European Union. A total of 51.9%, or 17,410,742 people voted to Leave, compared with 48.1%, or 16,141,241people who voted Remain. 24 June 2016
Pharmaceutical
The Indian government has withdrawn a Bill introduced in 2013 to amend the existing Drugs and Cosmetics Act, promising to ‘comprehensively review’ regulations to suit new science and research methods. 23 June 2016
Biosimilars
The US trade association representing pharmacy benefit managers has said that new bipartisan legislation will bring generic drugs to market sooner. 22 June 2016
Pharmaceutical
In our weekly expert view piece, Elisabethann Wright, partner at international law firm Hogan Lovells, outlines some of the potential risks if British voters opt to exit the European Union (EU). 21 June 2016
Biotechnology
Multinational pharmaceutical companies last week called for South Korea's government to help build a so-called "National Bio Cluster," proposed by a local business lobby group to foster the bio industry as a new growth engine, reports China’s state news agency Xinhua. 21 June 2016
Biosimilars
Groups representing Europe’s pharma, biotech and generics companies have welcomed the European Commission’s staging of a workshop on the uptake of biosimilars. 20 June 2016
Pharmaceutical
China’s State Council has formally authorized a pilot for a new drug marketing authorization holder (MAH) system for 10 of its 23 provinces. 20 June 2016
Pharmaceutical
The Ukraine Association of Pharmaceutical Research and Development (APRaD) has called its disclosure of information on transfers of value to health care professionals and organizations made in the country’s pharma industry in 2015 a step forward for transparency. 20 June 2016
Pharmaceutical
Leading global drugmakers operating in the Russian market have called on the country’s government to ease the current conditions for conducting clinical trials of their drugs in Russia, according to recent statements from the press-service of the Russian Ministry of Health. 20 June 2016
Biosimilars
Medicines for Europe, the trade group representing the continent’s generics and biosimilars industry, has said it will work with health ministers to ensure swift implementation of calls for greater pharma competition which were made in the council of the European Union this week. 17 June 2016
Generics
The US Senate Judiciary Committee introduced new legislation Tuesday, aimed at countering the growing issue of rising prescription drug prices in the USA and anti-competitive moves by pharmaceutical companies to delay lower-priced generic competition from entering the market. 15 June 2016
Pharmaceutical
Immediate contingency plans should be put in place to safeguard the UK’s science and innovation sector in case Britain votes to leave the EU, a government report has said. 14 June 2016
Pharmaceutical
Research findings from specialists treating advanced lung cancer have today highlighted worrying concerns that UK patients are being denied the best possible chance of survival. 14 June 2016
Pharmaceutical
The Colombian Ministry of Health has announced that negotiations with Swiss pharma giant Novartis over the price of its cancer drug Glivec (imatinib) have failed, and that Health Minister Alejandro Gaviria will proceed with the formal declaration that a compulsory license for the patents on the drug is in the public interest. 13 June 2016
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze